Scientific Literature Search

Source record

Genetic findings in a Turkish clinical cohort with hereditary Parkinson's disease.

Ozata Aksoy D, Tunca Y, Sonkaya AR, Torun D, Korucu O.

Neurogenetics · 2026-10-06

DOI: 10.1007/s10048-026-00949-5PMID: 42836888

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Clinical and biomarker predictors of α-synuclein seeding in cognitive impairment and motor parkinsonism.

Ye BS, VandeVrede L, Jeon S, Lee S, Choi M, Jeon S, Shin NY, Charters B, Plastini M, Kang S, Rim JH, Lim JB.

Parkinsonism Relat Disord · 2026-10-04

DOI: 10.1016/j.parkreldis.2026.108956PMID: 42854385

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

The Therapeutic Potential of MicroRNAs Delivered By Mesenchymal Stem Cells in Parkinson's Disease, Alzheimer's Disease, and Stroke: A Systematic Review of Preclinical Studies.

Przywara D, Petniak A, Gil-Kulik P.

Mol Neurobiol · 2026-10-03

DOI: 10.1007/s12035-026-06247-3PMID: 42828605

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Gowda N, Harish S.

Neurogenetics · 2026-10-02

DOI: 10.1007/s10048-026-00946-8PMID: 42825921

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.

Rava A, Di Trapano M, Tse C, Ji L, Bid HK, Trezza V.

Neurosci Biobehav Rev · 2026-10-02

DOI: 10.1016/j.neubiorev.2026.107005PMID: 42826598

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Susceptibility-Weighted Imaging in Patients with Corticobasal Syndrome or Progressive Supranuclear Palsy: Distribution of Iron Deposits Reflects Clinical Symptoms in 4-Repeat Tauopathies.

Migaleddu G, Del Prete E, Donatelli G, Frosini D, Ceravolo R, Cosottini M.

AJNR Am J Neuroradiol · 2026-10-01

DOI: 10.3174/ajnr.a9338PMID: 41951427

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum.

Roascio M, Antelmi E, Baldelli L, Biscarini F, Bonanni E, Brunetti V, Capriglia E, Geromino C, Casoni F, Cirillo F, Della Marca G, Di Laudo F, Ferini-Strambi L, Fernandes M, Figorilli M, Galbiati A, Gigli GL, Guarnieri B, Hoxhaj D, Lanza G, Liguori C, Maestri Tassoni M, Maio S, Malomo G, Marelli S, Mattioli P, Mulas M, Orso B, Pardini M, Plazzi G, Provini F, Pellitteri G, Puligheddu M, Terzaghi M, Pelletier A, Postuma RB, Arnulfo G, Arnaldi D, FARPRESTO consortium.

Brain · 2026-10-01

DOI: 10.1093/brain/awag193PMID: 42213896

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Are There Cognitive and Anxiety Improvements in People With Parkinson's Disease After Xbox Kinect Training Compared With No Intervention? A Non-Randomized Controlled Trial.

Ferreira da Silva EC, de Souza Morais W, Carregaro RL, Garcia PA, Leal JC, Mendes FADS.

Physiother Res Int · 2026-10-01

DOI: 10.1002/pri.70306PMID: 42576230

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

Shen H, Sun P, Ge B, Xiao J, Han X.

Clin Biochem · 2026-10-01

DOI: 10.1016/j.clinbiochem.2026.111213PMID: 42822624

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.

Chaparro-Solano HM, Saadatpour L, Yu JRT, Sonneborn C, Peixoto-Leal T, Piccinin CC, Anis S, Kaur H, Assaedi E, Mata IF, Fernandez HH.

Parkinsonism Relat Disord · 2026-10-01

DOI: 10.1016/j.parkreldis.2026.109000PMID: 42832827

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

The FOG-COA Protocol: Validation of Freezing of Gait Clinical Outcomes Assessments in Parkinson's Disease.

Howe EE, Ginis P, Ehgoetz Martens KA, Gilat M, Mancini M, Mckay JL, Nonnekes J, Mammen J, Adams JL, Cella D, Nieuwboer A, Horak F, Lewis SJG, Hausdorff JM.

Eur J Neurosci · 2026-10-01

DOI: 10.1111/ejn.70701PMID: 42888898

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Prediction of cognitive impairment in Parkinson's disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics.

Zhou Z, Liu J, Wang L, Lv H, Jiang W, Huang L, Zhang G, Ma R.

Front Aging Neurosci · 2026-09-30

DOI: 10.3389/fnagi.2026.1905374PMID: 42877199

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

7.691 articles found

Genetic findings in a Turkish clinical cohort with hereditary Parkinson's disease.

Clinical and biomarker predictors of α-synuclein seeding in cognitive impairment and motor parkinsonism.

The Therapeutic Potential of MicroRNAs Delivered By Mesenchymal Stem Cells in Parkinson's Disease, Alzheimer's Disease, and Stroke: A Systematic Review of Preclinical Studies.

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.

Susceptibility-Weighted Imaging in Patients with Corticobasal Syndrome or Progressive Supranuclear Palsy: Distribution of Iron Deposits Reflects Clinical Symptoms in 4-Repeat Tauopathies.

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum.

Are There Cognitive and Anxiety Improvements in People With Parkinson's Disease After Xbox Kinect Training Compared With No Intervention? A Non-Randomized Controlled Trial.

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.

The FOG-COA Protocol: Validation of Freezing of Gait Clinical Outcomes Assessments in Parkinson's Disease.

Prediction of cognitive impairment in Parkinson's disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics.

Filters